How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Cobalt 60 Radioactive Source Market
- By Application: Radiation Therapy, Sterilization of Medical Equipment, Food Irradiation, Industrial Radiography, Research and Development
- By Source Activity Level: Low Activity Sources (<100 Ci), Medium Activity Sources (100-1000 Ci), High Activity Sources (>1000 Ci)
- By Source Form: Sealed Sources, Unsealed Sources
- By End-User Industry: Healthcare Facilities, Pharmaceutical Manufacturing, Food Processing Industry, Industrial Manufacturing, Academic and Research Institutions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Radiation Therapy leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 10 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 258 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.162 →
- 11 Company Profiles 10 players: SWOT & benchmarking p.170 →
Full report · locked preview
Everything inside the Cobalt 60 Radioactive Source Market report
A complete, evidence-based study - 11 chapters and 108 sections covering market size, segmentation across 4 axes, regional analysis and 10 company profiles, forecast to 2033.
Segmentation covered
Application 5
Source Activity Level 3
Source Form 2
End-User Industry 5
Companies profiled
Nordion (a Sotera Health company)
Best Theratronics Ltd.
MDS Nordion
Eckert & Ziegler BEBIG
Isotope Products Laboratories (IPL)
BRIT (Board of Radiation and Isotope Technology)
China Isotope & Radiation Corporation (CIRC)
NTP Radioisotopes SOC Ltd.
Institute of Isotopes Co. Ltd. (Hungary)
Nuclear Energy Corporation of South Africa (Necsa)
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
10 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Nordion (a Sotera Health company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Best Theratronics Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →MDS Nordion
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Eckert & Ziegler BEBIG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Isotope Products Laboratories (IPL)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →BRIT (Board of Radiation and Isotope Technology)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →China Isotope & Radiation Corporation (CIRC)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →NTP Radioisotopes SOC Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Institute of Isotopes Co. Ltd. (Hungary)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.202 →Nuclear Energy Corporation of South Africa (Necsa)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,401M by 2033 · 9.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Radiation Therapy47.4
- Sterilization of Medical Equipment15.6
- Food Irradiation11.9
- Industrial Radiography16.7
- Research and Development8.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$871.1M → $1,584M · 7.8%
Europe$607.2M → $1,216M · 9.1%
Asia Pacific$554.4M → $1,203M · 10.2%
Latin America$343.2M → $661.8M · 8.6%
Middle East and Africa$264.0M → $538.2M · 9.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.312026
9.332027
9.342028
9.352029
9.372030
9.372031
9.392032
9.402033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Nordion (a Sotera Health company)21.0
- Best Theratronics Ltd.13.8
- MDS Nordion9.4
- Eckert & Ziegler BEBIG12.8
- Isotope Products Laboratories (IPL)8.2
- BRIT (Board of Radiation and Isotope Technology)6.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Application19.7%
Source Activity Level27.5%
Source Form40.0%
End-User Industry12.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.5
- Europe23.4
- Asia Pacific23.1
- Latin America12.7
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Nordion (a Sotera Health company) | 89 | 76 | 93 | 81 | 81 | 92 | 85 |
| Best Theratronics Ltd. | 81 | 69 | 82 | 74 | 89 | 91 | 81 |
| MDS Nordion | 75 | 75 | 63 | 86 | 77 | 86 | 77 |
| Eckert & Ziegler BEBIG | 60 | 59 | 59 | 82 | 68 | 70 | 66 |
| Isotope Products Laboratories (IPL) | 61 | 56 | 70 | 75 | 67 | 55 | 64 |
| BRIT (Board of Radiation and Isotope Technology) | 64 | 52 | 68 | 61 | 65 | 53 | 61 |
| China Isotope & Radiation Corporation (CIRC) | 42 | 56 | 62 | 66 | 61 | 42 | 55 |
| NTP Radioisotopes SOC Ltd. | 44 | 47 | 37 | 46 | 60 | 37 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Nordion (a Sotera Health company)
- Best Theratronics Ltd.
- MDS Nordion
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Nordion (a Sotera Health company) | ✓ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Best Theratronics Ltd. | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| MDS Nordion | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Eckert & Ziegler BEBIG | ✓ | ◐ | − | ◐ | ◐ | ✓ |
| Isotope Products Laboratories (IPL) | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| BRIT (Board of Radiation and Isotope Technology) | ◐ | − | ◐ | ◐ | ◐ | − |
| China Isotope & Radiation Corporation (CIRC) | − | ◐ | − | ◐ | ◐ | − |
| NTP Radioisotopes SOC Ltd. | − | − | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Nordion (a Sotera Health company)85
2Best Theratronics Ltd.81
3MDS Nordion77
4Eckert & Ziegler BEBIG66
5Isotope Products Laboratories (IPL)64
6BRIT (Board of Radiation and Isotope Technology)61
7China Isotope & Radiation Corporation (CIRC)55
8NTP Radioisotopes SOC Ltd.45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Nordion (a Sotera Health company)Best Theratronics Ltd.
Challenger1
Strong scale, closing on the leaders.
MDS Nordion
Contender3
Focused players with pockets of strength.
Eckert & Ziegler BEBIGIsotope Products Laboratories (IPL)BRIT (Board of Radiation and Isotope Technology)
Niche2
Specialists in a single segment or region.
China Isotope & Radiation Corporation (CIRC)NTP Radioisotopes SOC Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Cobalt 60 Radioactive Source Market — a $424M beachhead inside a $5.72B market.
Beachhead (SOM)$424Mobtainable near-term
Serviceable (SAM)$2.31Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Radiation Therapy
Best fit — highest urgency & budget in Application.
Economic buyer78 fit
Sterilization of Medical Equipment
Strong fit — clear ROI and a fast path to value.
End user66 fit
Food Irradiation
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Source Activity Level & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Source Form
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel30%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Cobalt 60 Radioactive Source Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified25%
Evaluation12%
Closed-won5%
$17.8KCAC
$83KLTV
4.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Cobalt 60 Radioactive Source Market is a durable-growth opportunity — $4.18B by 2033, compounding at 7.5%.
TAM · 2025$2.33Btoday
TAM · 2033$4.18Bforecast
CAGR7.5%2027–2033
Cumulative$28.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.18BTotal addressable market
SAM$1.70BServiceable available market
SOM$275MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.5% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
10+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.18BLarge & growingTAM by 2033 at 7.5% CAGR
$1.70BServiceable nowreachable with today’s model
$275MBeachhead winobtainable near-term share
10+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.26BBear4.9% CAGR
$4.18BBase7.5% CAGR
$5.35BBull10.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Source Activity Level optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Cobalt 60 Radioactive Source Market — a $4.32B market by 2033. Plan: grow share from 7.5% to 15.1%.
Market size · 2033$4.32Btotal addressable
Market CAGR11.6%2027–2033
Target share15.1%from 7.5% today
Revenue ambition$652Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.5% | 15.1% | Behind |
| Revenue | $345M | $652M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 37.9% | 43.9% | On track |
| Customer retention | 87.9% | 94.0% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Source Activity Level capability
A defensible second engine — invest in Source Activity Level to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Source Activity Level
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $84M capacity & capability investment
- Greenlight bolt-on M&A in Source Activity Level
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Cobalt 60 Radioactive Source Market conversation — a $6.10B market you can size, segment and defend in minutes.
Market size · 2033$6.10Btotal opportunity
Growth7.8%CAGR to 2033
Addressable buyers1,635+accounts in scope
Typical ROI6.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.9×return on cost, year one
< 2 mopayback period
$49K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
10+players profiled in this market
Coverage includes
Nordion (a Sotera Health company)Best Theratronics Ltd.MDS NordionEckert & Ziegler BEBIGIsotope Products Laboratories (IPL)BRIT (Board of Radiation and Isotope Technology)China Isotope & Radiation Corporation (CIRC)NTP Radioisotopes SOC Ltd.+2 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Cobalt 60 Radioactive Source Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Cobalt 60 Radioactive Source Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Cobalt Acetate Crystals Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportCobalt Acid Calcium Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportCobalt Acid Lithium Battery Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportCobalt Berylium Copper Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportCobalt bis(2-ethylhexanoate) Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportCobalt Boride Alloy Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportCobalt Carbonate Hydrate Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportCobalt Carbonate Hydroxide Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportCobalt Chloride Hexahydrate (7791-13-1) Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportCobalt Chrome Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportCobalt Chromium Alloys Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportCobalt Foils Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.